Bio-Rad Laboratories, founded in 2008, is a global leader in the Biotechnology and Health Care industries. With a team of over 8,000 employees, Bio-Rad is dedicated to advancing science and saving lives through innovative products. Their commitment to accelerating the discovery process for life science researchers and providing faster, better results for medical diagnostic labs is evident in their $3.56M Debt Financing investment on 22nd July 2011.
Their slogan, "We advance science and save lives, together," reflects their mission to build long-lasting customer relationships, fostering the introduction of new products and solutions that contribute to the research and development efforts. The company's focus on STEM fields, such as Research, Biology, and Chemistry, underscores their commitment to innovation and progress in the industry.
As a prominent player in the market, Bio-Rad's global network of operations caters to the needs of life science research and clinical diagnostics customers, addressing critical areas like Diabetes, Cancer Research, and HIV Research. The company's emphasis on advancing science and saving lives resonates through their extensive engagement in Laboratory and Peer-Reviewed research, making them a key contributor in the fight against diseases like AIDS, Cancer, and Diabetes.
With no specific mention of investors for their latest financing round, Bio-Rad Laboratories demonstrates financial stability and the potential for further growth within the biotechnology and healthcare sectors.
No recent news or press coverage available for Bio-Rad Laboratories.